Edition:
United Kingdom

Fagron NV (FAGRO.BR)

FAGRO.BR on Brussels Stock Exchange

12.65EUR
16 Feb 2018
Change (% chg)

€-0.02 (-0.16%)
Prev Close
€12.67
Open
€12.76
Day's High
€12.83
Day's Low
€12.47
Volume
178,603
Avg. Vol
252,604
52-wk High
€13.74
52-wk Low
€9.65

Chart for

About

Fagron NV, formerly Arseus NV, is a Belgium-based company that is active in the healthcare sector. It operates as a research and development (R&D) scientific pharmaceutical compounding supplier and operates through four segments: The Fagron Specialty Pharma Services segment comprises personalized medication that is produced in... (more)

Overall

Beta: 1.92
Market Cap(Mil.): €908.83
Shares Outstanding(Mil.): 71.84
Dividend: --
Yield (%): --

Financials

  Industry Sector
P/E (TTM): -- 31.10 16.64
EPS (TTM): -- -- --
ROI: -- 14.90 10.66
ROE: -- 16.41 14.30

BRIEF-Fagron FY Rebitda Increased 5.7% To 95.7 Million Euros

* REG-FAGRON TURNOVER INCREASED BY 3.6% TO € 436.9 MILLION AND NET PROFIT INCREASED TO € 47.0 MILLION

07 Feb 2018

BRIEF-Cannimed Therapeutics Announces Cannabis Distribution Agreement With Fagron NV

* CANNIMED THERAPEUTICS INC. ANNOUNCES STRATEGIC INTERNATIONAL CANNABIS DISTRIBUTION AGREEMENT WITH FAGRON NV

10 Jan 2018

BRIEF-Fagron appoints ‍Rafael Padilla to succeed Hans Stols as CEO

* ‍MR. STOLS WILL RESIGN FROM ALL HIS FUNCTIONS AND MANDATES WITH IMMEDIATE EFFECT​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

27 Nov 2017

BRIEF-Fagron Q3 turnover ‍​up at 103.6 million euros

* Q3 TURNOVER EUR ‍​103.6 MILLION VERSUS EUR 103.4 MILLION YEAR AGO

12 Oct 2017

BRIEF-Fagron acquires All Chemistry in Brazil

* FAGRON FURTHER EXECUTES BUY-AND-BUILD STRATEGY WITH ACQUISITION OF ALL CHEMISTRY IN BRAZIL Source text: http://bit.ly/2yJwvbB Further company coverage: (Gdynia Newsroom)

05 Oct 2017

Earnings vs. Estimates